Issue 2, 2024

An electron-accepting half-sandwich iridium(iii) complex for the treatment of hypoxic tumors via synergetic chemo- and phototherapy

Abstract

Tumor hypoxia is believed to be a major bottleneck in the clinical transformation of photodynamic therapy (PDT). Here, a half-sandwich iridium(III) complex [(η5-Cpxbiph)Ir(N^N-NDI)Cl]PF6 (Ir-NDI, Cpxbiph = tetramethyl(biphenyl)-cyclopentadienyl) bearing a naphthalene diimide (NDI) modified N^N-chelating ligand was designed to treat hypoxic tumors via synergetic chemo- and phototherapy. In vitro tests showed that Ir-NDI exhibited moderate dark cytotoxicity and potent photo-cytotoxicity against 4T1 murine breast cancer cells under both normoxic and hypoxic conditions. Mechanism studies indicated that Ir-NDI could induce the degradation of endogenous nicotinamide adenine dinucleotide (NADH) and glutathione (GSH) in 4T1 living cells and trigger cellular apoptosis and ferroptosis. In vivo studies demonstrated that Ir-NDI plus laser irradiation achieved significant tumor ablation, with a tumor-growth-inhibition (TGI) rate of up to 89%. Our research here presents a feasible approach for the treatment of hypoxic tumors via chem- and phototherapy of iridium(III) complexes.

Graphical abstract: An electron-accepting half-sandwich iridium(iii) complex for the treatment of hypoxic tumors via synergetic chemo- and phototherapy

Supplementary files

Article information

Article type
Research Article
Submitted
07 10 2023
Accepted
20 11 2023
First published
05 12 2023

Inorg. Chem. Front., 2024,11, 436-450

An electron-accepting half-sandwich iridium(III) complex for the treatment of hypoxic tumors via synergetic chemo- and phototherapy

Y. Yang, Y. Gao, J. Zhao and S. Gou, Inorg. Chem. Front., 2024, 11, 436 DOI: 10.1039/D3QI02047A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements